Company · CIK 0001631650 · SIC 2834 — Pharmaceutical Preparations
Aimmune Therapeutics, Inc. · AIMT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Douglas T. SheehySee Remarks | 12,500 | — | — | 45,668 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 11,875 | — | — | 21,250 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Eric BjerkholtChief Financial Officer | 13,125 | — | — | 32,857 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Mary M. RozenmanSee Remarks | 7,500 | — | — | 14,504 | — | plan? |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:05 pm EST | Jayson Donald Alexander DallasPresident and CEO, Director | 35,000 | — | — | 98,650 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:06 pm EST | Andrew OxtobyChief Commercial Officer | 12,000 | — | — | 12,000 | — | plan? |
| Nov 19, 2018 SForm 4 → | Nov 21, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 40,000 | $30.04 | $1,201,600 | 9,375 | −81.0% | plan? |
| Nov 19, 2018 MForm 4 → | Nov 21, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 40,000 | $3.02 | $120,880 | 49,375 | — | plan? |
| Nov 19, 2018 PForm 4 → | Nov 19, 8:12 pm EST | Jayson Donald Alexander DallasPresident and CEO, Director | 3,650 | $27.56 | $100,587 | 63,650 | +6.08% | plan? |
| Jun 19, 2018 AForm 4 → | Jun 19, 7:06 pm EDT | Jayson Donald Alexander DallasPresident and CEO, Director | 60,000 | — | — | 60,000 | — | plan? |
| Jun 13, 2018 PForm 4 → | Jun 14, 4:08 pm EDT | Eric BjerkholtChief Financial Officer | 1,600 | $30.41 | $48,663 | 19,485 | +8.95% | plan? |
| Jun 11, 2018 SForm 4 → | Jun 13, 4:06 pm EDT | Stephen George DillyPresident and CEO, Director | 29,457 | $30.83 | $908,301 | 315,308 | −8.54% | plan? |
| Jun 11, 2018 MForm 4 → | Jun 13, 4:06 pm EDT | Stephen George DillyPresident and CEO, Director | 29,457 | $3.02 | $89,022 | 344,765 | — | plan? |
| Jun 6, 2018 SForm 4 → | Jun 8, 5:50 pm EDT | Stephen George DillyPresident and CEO, Director | 105,169 | $30.92 | $3,251,993 | 315,308 | −25.0% | plan? |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:50 pm EDT | Stephen George DillyPresident and CEO, Director | 105,169 | $3.02 | $317,831 | 357,414 | — | plan? |
| Jun 1, 2018 SForm 4 → | Jun 5, 7:20 pm EDT | Stephen George DillySee Remarks, Director | 165,374 | $32.14 | $5,315,183 | 315,308 | −34.4% | plan? |
| May 23, 2018 AForm 4 → | May 24, 5:09 pm EDT | Patrick G EnrightDirector, 10% Owner | 3,750 | — | — | 26,619 | — | plan? |
| May 23, 2018 AForm 4 → | May 24, 5:09 pm EDT | Stacey Denenberg SeltzerDirector | 3,750 | — | — | 3,779 | — | plan? |
| May 23, 2018 AForm 4 → | May 24, 5:08 pm EDT | Gregory BeharDirector | 3,750 | — | — | 3,750 | — | plan? |
| May 23, 2018 AForm 4 → | May 24, 5:06 pm EDT | Mark T IwickiDirector | 3,750 | — | — | 33,125 | — | plan? |
| May 23, 2018 AForm 4 → | May 24, 5:06 pm EDT | Kathryn E FalbergDirector | 3,750 | — | — | 128,644 | — | plan? |
| May 23, 2018 AForm 4 → | May 24, 5:05 pm EDT | Mark McDadeDirector | 3,750 | — | — | 20,410 | — | plan? |
| May 22, 2018 SForm 4 → | May 24, 5:09 pm EDT | Douglas T. SheehySee Remarks | 3,296 | $33.00 | $108,768 | 33,079 | −9.06% | plan? |
| May 22, 2018 MForm 4 → | May 24, 5:09 pm EDT | Douglas T. SheehySee Remarks | 3,296 | $12.95 | $42,683 | 34,727 | — | plan? |
| Mar 5, 2018 SForm 4 → | Mar 6, 8:40 pm EST | Douglas T. SheehySee Remarks | 3,523 | $36.52 | $128,667 | 32,500 | −9.78% | plan? |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:42 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 9,375 | — | — | 9,375 | — | plan? |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:42 pm EST | Jeffrey H KnappChief Operating Officer | 9,375 | — | — | 12,151 | — | plan? |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:41 pm EST | Mary M. RozenmanSee Remarks | 6,875 | — | — | 7,004 | — | plan? |
| Mar 4, 2018 AMForm 4 → | Mar 6, 8:40 pm EST | Douglas T. SheehySee Remarks | 36,023 | $16.51 | $58,148 | 34,148 | — | plan? |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:40 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 9,375 | — | — | 9,375 | — | plan? |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:39 pm EST | Eric BjerkholtChief Financial Officer | 9,375 | — | — | 17,500 | — | plan? |
| Mar 1, 2018 SForm 4 → | Mar 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 1,807 | $33.10 | $59,812 | 129 | −93.3% | plan? |
| Mar 1, 2018 MForm 4 → | Mar 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 1,807 | $3.02 | $5,461 | 1,936 | — | plan? |
| Feb 26, 2018 PForm 4 → | Feb 26, 4:05 pm EST | Mark T IwickiDirector | 9,375 | $32.00 | $300,000 | 29,375 | +46.9% | plan? |
| Feb 26, 2018 PForm 4 → | Feb 26, 4:05 pm EST | Kathryn E FalbergDirector | 30,000 | $32.00 | $960,000 | 124,894 | +31.6% | plan? |
| Feb 26, 2018 PForm 4 → | Feb 26, 4:05 pm EST | Eric BjerkholtChief Financial Officer | 3,125 | $32.00 | $100,000 | 8,125 | +62.5% | plan? |
| Feb 22, 2018 PForm 4 → | Feb 26, 4:25 pm EST | Bakker Juliet Tammenoms10% Owner | 9,375 | $32.00 | $300,000 | 16,651 | +129% | plan? |
| Feb 22, 2018 PForm 4 → | Feb 26, 4:22 pm EST | Patrick G EnrightDirector, 10% Owner | 15,593 | $32.00 | $498,976 | 22,869 | +214% | plan? |
| Feb 5, 2018 SForm 4 → | Feb 7, 4:06 pm EST | Douglas T. SheehySee Remarks | 1,648 | $35.87 | $59,114 | 0 | −100% | plan? |
| Feb 5, 2018 MForm 4 → | Feb 7, 4:06 pm EST | Douglas T. SheehySee Remarks | 1,648 | $12.95 | $21,342 | 1,648 | — | plan? |
| Feb 1, 2018 SForm 4 → | Feb 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,592 | $35.36 | $233,088 | 129 | −98.1% | plan? |
| Feb 1, 2018 MForm 4 → | Feb 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,592 | $3.02 | $19,921 | 6,721 | — | plan? |
| Jan 24, 2018 SForm 4 → | Jan 26, 5:32 pm EST | Douglas T. SheehySee Remarks | 1,875 | $38.15 | $71,531 | 0 | −100% | plan? |
| Jan 24, 2018 MForm 4 → | Jan 26, 5:32 pm EST | Douglas T. SheehySee Remarks | 1,875 | $19.63 | $36,806 | 1,875 | — | plan? |
| Jan 12, 2018 SForm 4 → | Jan 16, 6:05 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 36,717 | $40.00 | $1,468,680 | 0 | −100% | plan? |
| Jan 12, 2018 MForm 4 → | Jan 16, 6:05 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 36,717 | $11.45 | $420,410 | 9,933 | — | plan? |
| Jan 4, 2018 SForm 4 → | Jan 8, 4:07 pm EST | Douglas T. SheehySee Remarks | 1,648 | $37.33 | $61,520 | 0 | −100% | plan? |
| Jan 4, 2018 MForm 4 → | Jan 8, 4:07 pm EST | Douglas T. SheehySee Remarks | 1,648 | $12.95 | $21,342 | 1,648 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 4, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,591 | $37.11 | $244,590 | 129 | −98.1% | plan? |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,591 | $3.02 | $19,918 | 6,720 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 4, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 75,000 | $37.14 | $2,785,190 | 0 | −100% | plan? |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 75,000 | $3.02 | $226,650 | 75,000 | — | plan? |
| Dec 27, 2017 SForm 4 → | Dec 29, 5:26 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 3,283 | $40.00 | $131,320 | 0 | −100% | plan? |
| Dec 27, 2017 MForm 4 → | Dec 29, 5:26 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 3,283 | $11.45 | $37,590 | 3,283 | — | plan? |
| Dec 26, 2017 SForm 4 → | Dec 28, 5:45 pm EST | Mary M. RozenmanSee Remarks | 75,010 | $38.88 | $2,916,086 | 129 | −99.8% | plan? |
| Dec 26, 2017 MForm 4 → | Dec 28, 5:45 pm EST | Mary M. RozenmanSee Remarks | 75,010 | $3.02 | $226,680 | 75,139 | — | plan? |
| Dec 26, 2017 SForm 4 → | Dec 28, 5:43 pm EST | Douglas T. SheehySee Remarks | 1,875 | $39.44 | $73,950 | 0 | −100% | plan? |
| Dec 26, 2017 MForm 4 → | Dec 28, 5:43 pm EST | Douglas T. SheehySee Remarks | 1,875 | $19.63 | $36,806 | 1,875 | — | plan? |
| Dec 6, 2017 JForm 4 → | Dec 8, 4:31 pm EST | Stacey Denenberg SeltzerDirector | 29 | — | — | 29 | — | plan? |
| Dec 4, 2017 SForm 4 → | Dec 6, 4:05 pm EST | Douglas T. SheehySee Remarks | 1,906 | $38.66 | $73,686 | 0 | −100% | plan? |
| Dec 4, 2017 MForm 4 → | Dec 6, 4:05 pm EST | Douglas T. SheehySee Remarks | 1,906 | $12.95 | $24,683 | 1,906 | — | plan? |
| Nov 30, 2017 SForm 4 → | Dec 4, 4:05 pm EST | Douglas T. SheehySee Remarks | 3,750 | $37.00 | $138,750 | 0 | −100% | plan? |
| Nov 30, 2017 MForm 4 → | Dec 4, 4:05 pm EST | Douglas T. SheehySee Remarks | 3,750 | $19.63 | $73,613 | 3,750 | — | plan? |
| Nov 9, 2017 SForm 4 → | Nov 13, 5:26 pm EST | Douglas T. SheehySee Remarks | 1,905 | $33.00 | $62,865 | 0 | −100% | plan? |
| Nov 9, 2017 MForm 4 → | Nov 13, 5:26 pm EST | Douglas T. SheehySee Remarks | 1,905 | $12.95 | $24,670 | 1,905 | — | plan? |
| Oct 23, 2017 SForm 4 → | Oct 25, 4:05 pm EDT | Stephen George DillySee Remarks, Director | 100,000 | $33.55 | $3,354,538 | 315,308 | −24.1% | plan? |
| Oct 23, 2017 SForm 4 → | Oct 25, 4:05 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | $34.06 | $340,610 | 0 | −100% | plan? |
| Oct 23, 2017 MForm 4 → | Oct 25, 4:05 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | $11.45 | $114,500 | 10,000 | — | plan? |
| Oct 23, 2017 SForm 4 → | Oct 25, 4:05 pm EDT | Douglas T. SheehySee Remarks | 47,425 | $34.44 | $1,633,514 | 0 | −100% | plan? |
| Oct 23, 2017 MForm 4 → | Oct 25, 4:05 pm EDT | Douglas T. SheehySee Remarks | 47,425 | $14.80 | $701,829 | 13,125 | — | plan? |
| Oct 16, 2017 SForm 4 → | Oct 18, 7:59 pm EDT | Stephen George DillyPresident and CEO, Director | 1,154 | $26.24 | $30,279 | 415,308 | −0.28% | plan? |
| Oct 12, 2017 GMForm 4 → | Jun 5, 2018, 7:20 pm EDT | Stephen George DillySee Remarks, Director | 175,126 | $3.02 | $499,777 | 354,133 | — | plan? late |
| Oct 4, 2017 SForm 4 → | Oct 6, 6:02 pm EDT | Stephen George DillyPresident and CEO, Director | 98,846 | $26.24 | $2,593,317 | 416,462 | −19.2% | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 4:06 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | $25.00 | $250,000 | 0 | −100% | plan? |
| Sep 25, 2017 MForm 4 → | Sep 27, 4:06 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | $11.45 | $114,500 | 10,000 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 4:05 pm EDT | Stephen George DillyPresident and CEO, Director | 100,000 | $25.01 | $2,500,790 | 515,308 | −16.3% | plan? |
| Sep 25, 2017 SForm 4 → | Sep 27, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | $25.00 | $500,000 | 0 | −100% | plan? |
| Sep 25, 2017 MForm 4 → | Sep 27, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | $3.02 | $60,440 | 20,000 | — | plan? |
| Sep 7, 2017 SForm 4 → | Sep 11, 5:17 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | $22.50 | $675,000 | 129 | −99.6% | plan? |
| Sep 7, 2017 MForm 4 → | Sep 11, 5:17 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | $3.02 | $90,660 | 30,129 | — | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 18,390 | $22.00 | $404,615 | 0 | −100% | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 18,390 | $3.02 | $55,575 | 15,167 | — | plan? |
| Aug 23, 2017 GForm 4 → | Sep 27, 4:05 pm EDT | Stephen George DillyPresident and CEO, Director | 205,612 | — | — | 20,656 | — | plan? late |
| Jul 27, 2017 SForm 4 → | Jul 31, 5:50 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 500 | $22.00 | $11,000 | 0 | −100% | plan? |
| Jul 27, 2017 MForm 4 → | Jul 31, 5:50 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 500 | $3.02 | $1,511 | 500 | — | plan? |
| Jul 26, 2017 SForm 4 → | Jul 28, 4:31 pm EDT | Stephen George DillyPresident and CEO, Director | 50,000 | $21.46 | $1,073,110 | 615,308 | −7.52% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 25, 6:35 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 6,110 | $22.00 | $134,420 | 0 | −100% | plan? |
| Jul 21, 2017 MForm 4 → | Jul 25, 6:35 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 6,110 | $3.02 | $18,464 | 4,650 | — | plan? |
| Jul 21, 2017 SForm 4 → | Jul 21, 7:05 pm EDT | Douglas T. SheehySee Remarks | 7,460 | $21.66 | $161,558 | 0 | −100% | plan? |
| Jul 13, 2017 SForm 4 → | Jul 17, 4:31 pm EDT | Mary M. RozenmanSee Remarks | 14,940 | $21.44 | $320,247 | 129 | −99.1% | plan? |
| Jul 13, 2017 MForm 4 → | Jul 17, 4:31 pm EDT | Mary M. RozenmanSee Remarks | 14,940 | $3.02 | $45,149 | 429 | — | plan? |
| Jul 3, 2017 SForm 4 → | Jul 6, 5:01 pm EDT | Mary M. RozenmanSee Remarks | 45,060 | $20.85 | $939,390 | 129 | −99.7% | plan? |
| Jul 3, 2017 MForm 4 → | Jul 6, 5:01 pm EDT | Mary M. RozenmanSee Remarks | 45,060 | $3.02 | $136,171 | 15,189 | — | plan? |
| Jul 3, 2017 SForm 4 → | Jul 6, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | $20.26 | $303,911 | 0 | −100% | plan? |
| Jul 3, 2017 MForm 4 → | Jul 6, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | $3.02 | $45,330 | 15,000 | — | plan? |
| Jun 23, 2017 SForm 4 → | Jun 27, 4:06 pm EDT | Stephen George DillyPresident and CEO, Director | 49,400 | $20.21 | $998,591 | 665,308 | −6.91% | plan? |
| May 12, 2017 PForm 4 → | May 15, 4:49 pm EDT | Eric BjerkholtChief Financial Officer | 5,000 | $19.84 | $99,210 | 5,000 | — | plan? |
| May 10, 2017 SForm 4 → | May 12, 4:07 pm EDT | Stephen George DillySee Remarks, Director | 600 | $20.15 | $12,090 | 714,708 | −0.08% | plan? |
| Apr 4, 2017 FForm 4 → | Apr 6, 4:05 pm EDT | Douglas T. SheehySee Remarks | 4,540 | $21.00 | $95,340 | 7,460 | — | plan? |
| Apr 3, 2017 SForm 4 → | Apr 5, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 15,000 | $21.58 | $323,736 | 20,681 | −42.0% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Douglas T. SheehySee Remarks | 75,000 | — | — | 75,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 71,250 | — | — | 71,250 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Eric BjerkholtChief Financial Officer | 78,750 | — | — | 78,750 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:06 pm EST | Mary M. RozenmanSee Remarks | 45,000 | — | — | 45,000 | — | |
| Feb 22, 2019 AForm 4 → | Feb 26, 4:05 pm EST | Jayson Donald Alexander DallasPresident and CEO, Director | 210,000 | — | — | 210,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:06 pm EST | Andrew OxtobyChief Commercial Officer | 150,000 | — | — | 150,000 | — | |
| Nov 19, 2018 MForm 4 → | Nov 21, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 40,000 | — | — | 53,400 | — | |
| Jun 19, 2018 AForm 4 → | Jun 19, 7:06 pm EDT | Jayson Donald Alexander DallasPresident and CEO, Director | 350,000 | — | — | 350,000 | — | |
| Jun 11, 2018 MForm 4 → | Jun 13, 4:06 pm EDT | Stephen George DillyPresident and CEO, Director | 29,457 | — | — | 295,942 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:50 pm EDT | Stephen George DillyPresident and CEO, Director | 105,169 | — | — | 325,399 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 7:20 pm EDT | Stephen George DillySee Remarks, Director | 165,374 | — | — | 430,568 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:09 pm EDT | Patrick G EnrightDirector, 10% Owner | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:09 pm EDT | Stacey Denenberg SeltzerDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:08 pm EDT | Gregory BeharDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:06 pm EDT | Mark T IwickiDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:06 pm EDT | Kathryn E FalbergDirector | 7,500 | — | — | 7,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 5:05 pm EDT | Mark McDadeDirector | 7,500 | — | — | 7,500 | — | |
| May 22, 2018 MForm 4 → | May 24, 5:09 pm EDT | Douglas T. SheehySee Remarks | 3,296 | — | — | 63,649 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:42 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 56,250 | — | — | 56,250 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:42 pm EST | Jeffrey H KnappChief Operating Officer | 56,250 | — | — | 56,250 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:41 pm EST | Mary M. RozenmanSee Remarks | 41,250 | — | — | 41,250 | — | |
| Mar 4, 2018 AMForm 4 → | Mar 6, 8:40 pm EST | Douglas T. SheehySee Remarks | 78,523 | — | — | 66,945 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:40 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 56,250 | — | — | 56,250 | — | |
| Mar 4, 2018 AForm 4 → | Mar 6, 8:39 pm EST | Eric BjerkholtChief Financial Officer | 56,250 | — | — | 56,250 | — | |
| Mar 1, 2018 MForm 4 → | Mar 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 1,807 | — | — | 105,436 | — | |
| Feb 5, 2018 MForm 4 → | Feb 7, 4:06 pm EST | Douglas T. SheehySee Remarks | 1,648 | — | — | 68,593 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,592 | — | — | 107,243 | — | |
| Jan 24, 2018 MForm 4 → | Jan 26, 5:32 pm EST | Douglas T. SheehySee Remarks | 1,875 | — | — | 69,375 | — | |
| Jan 12, 2018 MForm 4 → | Jan 16, 6:05 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 36,717 | — | — | 190,000 | — | |
| Jan 4, 2018 MForm 4 → | Jan 8, 4:07 pm EST | Douglas T. SheehySee Remarks | 1,648 | — | — | 70,241 | — | |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:05 pm EST | Mary M. RozenmanSee Remarks | 6,591 | — | — | 113,835 | — | |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 75,000 | — | — | 93,400 | — | |
| Dec 27, 2017 MForm 4 → | Dec 29, 5:26 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 3,283 | — | — | 226,717 | — | |
| Dec 26, 2017 MForm 4 → | Dec 28, 5:45 pm EST | Mary M. RozenmanSee Remarks | 75,010 | — | — | 120,426 | — | |
| Dec 26, 2017 MForm 4 → | Dec 28, 5:43 pm EST | Douglas T. SheehySee Remarks | 1,875 | — | — | 71,250 | — | |
| Dec 4, 2017 MForm 4 → | Dec 6, 4:05 pm EST | Douglas T. SheehySee Remarks | 1,906 | — | — | 71,889 | — | |
| Nov 30, 2017 MForm 4 → | Dec 4, 4:05 pm EST | Douglas T. SheehySee Remarks | 3,750 | — | — | 73,125 | — | |
| Nov 9, 2017 MForm 4 → | Nov 13, 5:26 pm EST | Douglas T. SheehySee Remarks | 1,905 | — | — | 73,795 | — | |
| Oct 23, 2017 MForm 4 → | Oct 25, 4:05 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | — | — | 230,000 | — | |
| Oct 23, 2017 MForm 4 → | Oct 25, 4:05 pm EDT | Douglas T. SheehySee Remarks | 47,425 | — | — | 76,875 | — | |
| Sep 25, 2017 MForm 4 → | Sep 27, 4:06 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 10,000 | — | — | 240,000 | — | |
| Sep 25, 2017 MForm 4 → | Sep 27, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | — | — | 168,400 | — | |
| Sep 7, 2017 MForm 4 → | Sep 11, 5:17 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | — | — | 195,436 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 18,390 | — | — | 188,400 | — | |
| Jul 27, 2017 MForm 4 → | Jul 31, 5:50 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 500 | — | — | 206,790 | — | |
| Jul 21, 2017 MForm 4 → | Jul 25, 6:35 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 6,110 | — | — | 207,290 | — | |
| Jul 13, 2017 MForm 4 → | Jul 17, 4:31 pm EDT | Mary M. RozenmanSee Remarks | 14,940 | — | — | 225,436 | — | |
| Jul 3, 2017 MForm 4 → | Jul 6, 5:01 pm EDT | Mary M. RozenmanSee Remarks | 45,060 | — | — | 225,319 | — | |
| Jul 3, 2017 MForm 4 → | Jul 6, 4:05 pm EDT | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | — | — | 213,400 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:06 pm EDT | Kathryn E FalbergDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:06 pm EDT | Stacey Denenberg SeltzerDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Patrick G EnrightDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Mark T IwickiDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Gregory BeharDirector | 17,500 | — | — | 17,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 4:05 pm EDT | Mark McDadeDirector | 17,500 | — | — | 17,500 | — | |
| Apr 28, 2017 AForm 4 → | May 1, 4:33 pm EDT | Eric BjerkholtChief Financial Officer | 270,000 | — | — | 270,000 | — | |
| Apr 3, 2017 MForm 4 → | Apr 5, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 15,000 | — | — | 303,794 | — | |
| Mar 21, 2017 MForm 4 → | Mar 23, 4:05 pm EDT | Warren L. DeSouzaChief Financial Officer | 10,000 | — | — | 318,794 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:40 pm EST | Jeffrey H KnappChief Operating Officer | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:40 pm EST | Daniel C Adelman M.D.Chief Medical Officer | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:39 pm EST | Douglas T. SheehySee Remarks | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:38 pm EST | Stephen George DillySee Remarks, Director | 240,000 | — | — | 240,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:36 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 90,000 | — | — | 90,000 | — | |
| Feb 24, 2017 AForm 4 → | Feb 24, 6:36 pm EST | Mary M. RozenmanSee Remarks | 60,000 | — | — | 60,000 | — | |
| Jan 11, 2017 MForm 4 → | Jan 13, 4:05 pm EST | Warren L. DeSouzaChief Financial Officer | 20,681 | — | — | 328,794 | — | |
| Nov 23, 2016 AForm 4 → | Nov 28, 4:05 pm EST | Gregory BeharDirector | 39,510 | — | — | 39,510 | — | |
| Nov 11, 2016 MForm 4 → | Nov 15, 4:06 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 20,000 | — | — | 228,400 | — | |
| Nov 8, 2016 MForm 4 → | Nov 10, 4:05 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 15,000 | — | — | 248,400 | — | |
| Nov 4, 2016 MForm 4 → | Nov 4, 4:08 pm EDT | Mary M. RozenmanSee Remarks | 24,096 | — | — | 270,379 | — | |
| Oct 5, 2016 MForm 4 → | Oct 7, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 25,000 | — | — | 294,475 | — | |
| Sep 8, 2016 MForm 4 → | Sep 9, 4:05 pm EDT | Mary M. RozenmanSee Remarks | 30,000 | — | — | 319,475 | — | |
| Jun 24, 2016 AForm 4 → | Jun 24, 5:20 pm EDT | Daniel C Adelman M.D.Chief Medical Officer | 250,000 | — | — | 250,000 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:06 pm EDT | Mark T IwickiDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:06 pm EDT | Patrick G EnrightDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:05 pm EDT | Mark McDadeDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:05 pm EDT | Kathryn E FalbergDirector | 19,755 | — | — | 19,755 | — | |
| May 25, 2016 AForm 4 → | May 27, 4:05 pm EDT | Stacey Denenberg SeltzerDirector | 19,755 | — | — | 19,755 | — | |
| Apr 29, 2016 AForm 4 → | Apr 29, 8:15 pm EDT | Douglas T. SheehySee Remarks | 110,000 | — | — | 110,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:47 pm EST | Susan E. BarrowcliffeGeneral Manager, Europe | 80,000 | — | — | 80,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:43 pm EST | Jeffrey H KnappChief Operating Officer | 250,000 | — | — | 250,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:42 pm EST | Warren L. DeSouzaChief Financial Officer | 80,000 | — | — | 80,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:41 pm EST | Stephen George DillySee Remarks, Director | 240,000 | — | — | 240,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:41 pm EST | Mary M. RozenmanSee Remarks | 80,000 | — | — | 80,000 | — | |
| Feb 26, 2016 AForm 4 → | Feb 26, 7:35 pm EST | Robert Myles ElfontChief Medical Officer | 80,000 | — | — | 80,000 | — | |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:49 am EDT | Longitude Capital Partners II, LLC +310% Owner | 7,122,130 | — | — | 0 | — | |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:46 am EDT | Foresite Capital Management II, LLC +410% Owner | 3,775,400 | — | — | 0 | — | |
| Aug 11, 2015 CForm 4 → | Aug 11, 11:29 am EDT | Patrick G EnrightDirector, 10% Owner | 7,122,130 | — | — | 0 | — |